iPharmaCenter|Healthcare| Pharma| Pharmaceutical industry| News|Blogs

ipharmaservices

China's National Medical Products Administration (NMPA) has accepted Astellas Pharma's Xtandi (enzalutamide) New Drug Application (NDA)...

ipharmaservices

Esophageal squamous cell carcinoma | News | Updates | iPharmaCenter

BeiGene, a prominent global biotechnology company, has recently shared positive regulatory updates regarding its innovative cancer...